Literature DB >> 24232313

Long-term outcomes and risk factors for failure with the EX-press glaucoma drainage device.

C Mariotti1, E Dahan2, M Nicolai1, L Levitz2, S Bouee3.   

Abstract

PURPOSE: To report on the long-term outcomes and risk factors for failure with the EX-PRESS shunt implanted under a scleral flap. SETTINGS: Eye Department, University of Ancona, Ancona, Italy and the Oxford Eye Center, University of Witwatersrand, Johannesburg, South Africa.
METHODS: The medical records of glaucoma patients who underwent consecutive EX-PRESS implantations under a scleral flap between 2000 and 2009 were reviewed. The operations were performed by two experienced surgeons using an identical surgical technique. The potential risk factors for failure that were analysed included age, sex, race, glaucoma type, previous antiglaucoma medications, previous glaucoma surgeries, diabetes, and smoking. Complete success was defined as postoperative intraocular pressure (IOP) 5 mm Hg>IOP<18 mm Hg without antiglaucoma medications. Qualified success was defined as 5 mm Hg>IOP<18 mm Hg with or without antiglaucoma medications.
RESULTS: Two hundred and forty-eight eyes of 211 consecutive patients were included. The mean IOP was reduced from 27.63 ± 8.26 mm Hg preoperatively (n=248) to 13.95 ± 2.70 mm Hg at 5 years (n=95). The mean follow-up was 3.46 ± 1.76 years. Complete and qualified success rates decreased gradually from 83% and 85% at 1 year to 57% and 63% at 5 years follow-up, respectively. The risk factors for failure were diabetes, non-Caucasian race, and previous glaucoma surgery. Complete success rates of diabetic patients and non-Caucasian patients decreased from 63% and 75% at 1 year to 42% and 40% at 5 years follow-up, respectively.
CONCLUSIONS: EX-PRESS success rates decrease over time but compare favourably with trabeculectomy literature data. The main identifiable risk factors for failure are diabetes, non-Caucasian race, and previous glaucoma surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24232313      PMCID: PMC3890762          DOI: 10.1038/eye.2013.234

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  41 in total

1.  A comparison of the Ex-PRESS™ mini glaucoma shunt with standard trabeculectomy in the surgical treatment of glaucoma.

Authors:  Lionel Marzette; Leon W Herndon
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2011 Nov-Dec

2.  Increased levels of transforming growth factor-betal and -beta2 in the aqueous humor of patients with neovascular glaucoma.

Authors:  Xiao-Bo Yu; Xing-Huai Sun; Elie Dahan; Wen-Yi Guo; Shao-Hong Qian; Fan-Rong Meng; Yue-Lian Song; Guy J Ben Simon
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2007 Jan-Feb

3.  What is new after 40 years of glaucoma implants.

Authors:  Jeffrey Freedman
Journal:  J Glaucoma       Date:  2010 Oct-Nov       Impact factor: 2.503

4.  Failure of filtration operations in the African.

Authors:  N H Welsh
Journal:  Br J Ophthalmol       Date:  1970-09       Impact factor: 4.638

5.  Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient: a prospective, randomised study.

Authors:  E Dahan; G J Ben Simon; A Lafuma
Journal:  Eye (Lond)       Date:  2012-02-17       Impact factor: 3.775

6.  The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty.

Authors: 
Journal:  Am J Ophthalmol       Date:  2002-10       Impact factor: 5.258

7.  A twenty-year follow-up study of trabeculectomy: risk factors and outcomes.

Authors:  John Landers; Keith Martin; Nicholas Sarkies; Rupert Bourne; Peter Watson
Journal:  Ophthalmology       Date:  2011-12-23       Impact factor: 12.079

8.  Efficacy and safety of a steel drainage device implanted under a scleral flap.

Authors:  Fabio De Feo; Alessandro Bagnis; Graziano Bricola; Riccardo Scotto; Carlo Enrico Traverso
Journal:  Can J Ophthalmol       Date:  2009-08       Impact factor: 1.882

9.  Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery.

Authors:  D C Broadway; I Grierson; C O'Brien; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1994-11

10.  Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes.

Authors:  Yuko Ochiai; Haruyuki Ochiai
Journal:  Jpn J Ophthalmol       Date:  2002 May-Jun       Impact factor: 2.447

View more
  24 in total

1.  Evaluation of the Ex-PRESS(®) P-50 implant under scleral flap in combined cataract and glaucoma surgery.

Authors:  Valentín Huerva; Jordi Soldevila; Francisco J Ascaso; Laura Lavilla; M Jesús Muniesa; M Carmen Sánchez
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

2.  Ex-PRESS implantation with phacoemulsification in POAG versus CPACG.

Authors:  Jie Lan; Da-Peng Sun; Jie Wu; Ya-Ni Wang; Li-Xin Xie
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

3.  RE: Long-term outcomes and risk factors for failure with the EX-press glaucoma drainage device.

Authors:  I Georgalas; D Papaconstantinou; C Koutsandrea
Journal:  Eye (Lond)       Date:  2014-05-09       Impact factor: 3.775

4.  Response to: RE: Long-term outcomes and risk factors for failure with the EX-press glaucoma drainage device.

Authors:  C Mariotti; E Dahan; M Nicolai; L Levitz; S Bouee
Journal:  Eye (Lond)       Date:  2014-05-09       Impact factor: 3.775

5.  Long-term results of viscocanalostomy and phacoviscocanalostomy: a twelve-year follow-up study.

Authors:  Uzeyir Gunenc; Taylan Ozturk; Gul Arikan; Nilufer Kocak
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

6.  Effect of glaucoma implant surgery on intraocular pressure reduction, flare count, anterior chamber depth, and corneal endothelium in primary open-angle glaucoma.

Authors:  Kyoko Ishida; Naoya Moroto; Kazuhiro Murata; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2017-04-03       Impact factor: 2.447

7.  Clinical research of EX-PRESS drainage device and modified trabeculectomy combined with intravitreal conbercept treatment for neovascular glaucoma.

Authors:  Peng Li; Qing Liu; Xiao-Min Liu; Li Wang; Zhao-Jiang Du; Qian-Yan Kang
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

Review 8.  Association Between Diabetes, Diabetic Retinopathy, and Glaucoma.

Authors:  Yangjiani Li; William Mitchell; Tobias Elze; Nazlee Zebardast
Journal:  Curr Diab Rep       Date:  2021-09-08       Impact factor: 5.430

9.  Risk factors for Ex-Press® surgery failure.

Authors:  Mitsuya Otsuka; Naoki Tojo; Atsushi Hayashi
Journal:  Int Ophthalmol       Date:  2022-10-13       Impact factor: 2.029

Review 10.  EX-PRESS Glaucoma Filtration Device: efficacy, safety, and predictability.

Authors:  Jessica E Chan; Peter A Netland
Journal:  Med Devices (Auckl)       Date:  2015-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.